Iodine-131-SGMIB anti-HER2 monoclonal antibody

N/A

Report date: 2025/09/12 15:58:00

Base Information

Drug NameIodine-131-SGMIB anti-HER2 monoclonal antibody

Drug Alias Name[131I]-SGMIB Anti-HER2-VHH1131I-SGMIB-anti-HER2-VHH1Iodine-131-SGMIB-anti-HER2-VHH1CAM-H2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Iodine > 131I +[4]

Mechanisms of ActionIonising radiation emittersReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsStomach NeoplasmsEsophageal NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumCanadaUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCamel-Ids Nv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPrecirix

Active IndicationsN/A

Inactive IndicationsStomach NeoplasmsEsophageal NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A